IGF2 and cancer: For example, Denley et al. [40] suggested that inhibiting IGF-II (Insulin-like Growth Factor II) has a desirable effect for cancer therapy, but it seems that inhibition of other Insulin receptor (IR) signals affect glucose metabolism.